Significance of Neuroscience Buoyant With High Prevalence of Brain and Nervous System Conditions
Neuroscience continues to be one of the most sought-after areas of research. With the rising prevalence of neurological disorders worldwide, the need for superior patient outcomes is also mounting, thereby pushing the expanse of the global neuroscience market. Neuroscience research is advancing at a rapid pace, making exciting progress on a wide variety of issues that range from the slowing of degenerative diseases such as amyotrophic lateral sclerosis (ALS), Huntington’s disease, and Parkinson’s, to discoveries on how the brain develops in early childhood.
There are more than 1,000 (heterogeneous group of) disorders of the brain, and nervous system, including -
Critical Need for Effective Therapeutics Fuels Neuroscience Market Growth
The brain is the pivotal hub of our central nervous system. A complex, sophisticated system, its nervous tendrils permeate every inch of our bodies, ultimately regulating, and coordinating the body's basic functions, and activities. Due to its vast structural, and functional intricacy, neuroscientists have the daunting task of trying to understand how all these billions of neurons in the brain, and nervous system work. The aetiology of these diseases is still not completely understood, and a majority of medication only treats the symptoms. There is an urgent need to develop novel therapies for better outcomes. Biological assays, including aggregation, cytotoxicity, and signalling assays are vital in aiding researchers to better comprehend the underlying mechanisms of these conditions in addition to discovering promising treatments in the primary stages of drug development.
Technology Is Facelifting Modern Neuroscience to Enable Better Understanding of Brain
Neuroscience is panacea for curing diseases. Although there has been incredible progress, there is still much left to discover, giving the global neuroscience market a vast potential.
New techniques such as special electrodes that can touch the surface of cells, electroceuticals to regulate nerve signals, neuro-regeneration, genomic sequencing, and genome editing, optical imaging – (diffuse optical imaging (DOI), functional ultrasound brain imaging, from Iconeus, is the next frontier in pre-clinical neuroscience), human brain scanning machines, and silicon chips containing artificial brain circuits, transcranial magnetic stimulation (TMS), liposomal-based strategies, light therapy consisting of controlled exposure to natural daylight or artificial light of specific wavelengths, and WuXi AppTec are all changing the face of the global neuroscience market. With life expectancies climbing worldwide, treating health at the level of the brain will become increasingly important to global human wellbeing.
Neuroscience Market Mental Health Problems Exert an Enormous Social and Economic Burden Demanding
According to the Global Burden of Disease study, neuropsychiatric disorders attribute for over 10% of the global burden of disease. As per The UN General Assembly Report of December, 2017, neurological disorders are the leading cause of disability, and the second leading cause of death worldwide. The World Health Organization (WHO) assesses that 10.8 million people die every year due to neurological disorders.
Global Neuroscience Market Set for Notable Growth as Research Efforts Firm up and Investments Flood in
There has been a rapid rise in total neuroscience research, with China becoming a major player pressuring the US into an arms race of the brain. Investment initiatives around the globe such as Obama’s Brain Initiative, as well as scores of research pledges on the horizon that outpace any other scientific domain are also heavily contributing towards the growth of the neuroscience market.
Global Neuroscience Market: Key Players
Biogen, Pfizer, Novartis, Allergan, J&J, Teva, Syanofi, Shire, UCB, and Otsuka are the top 10 companies with high neurology product sales in the global neuroscience market. AbbVie, Amgen, AstraZeneca, Athira Pharma, Balance Therapeutics, BioArctic, biOasis, Bristol-Myers Squibb, Cerevel Therapeutics, Focus@Will, Genesis Therapeutics, Intra-Cellular THERAPIES, Ipsen, Koniku, Libra Therapeutics, Merck & Co., Inc. (aka MSD), Minerva Neurosciences, Neurocrine, Regeneron Pharmaceuticals, Roche, SciNeuro Pharmaceuticals, Titan Pharmaceuticals, Tranquis Therapeutics, and Vigil Neuroscience are the prominent pharmacological and biological treatment companies.
Besides, Kernel, Dreem, Thync, Halo Neuroscience, Synchron, BrainCo, Inc., Neurable, Neuralink, Flow Neuroscience, Cognixion, Bitbrain Technologies, Paradromics, MELTIN MMI, Neuros Medical, NextMind, Emotiv, Q30 Innovations, BIOS, NeuroScouting, NeuroPace, and MindMaze constitute the key companies that predominantly focus on brain-machine interfaces, neuroprosthetics, neurostimulation, neuromonitoring, and implantable devices.
Global Neuroscience Market is Segmented as Follows:
By Component Type
By End User
By Geography
Key Elements Included In The Study: Global Neuroscience Market
Post Sale Support, Research Updates & Offerings
We value the trust shown by our customers in Fairfield Market Research. We support our clients through our post sale support, research updates and offerings.
Disclaimer:
Considering the volatility of business today, traditional approaches to strategizing a game plan can be unfruitful if not detrimental. True ambiguity is no way to determine a forecast. A myriad of predetermined factors must be accounted for such as the degree of risk involved, the magnitude of circumstances, as well as conditions or consequences that are not known or unpredictable. To circumvent binary views that cast uncertainty, the application of market research intelligence to strategically posture, move, and enable actionable outcomes is necessary.
View Methodology